By inhibiting thrombomodulin (THBD) signaling, a key pathway in the fate of senescent cells by vorapaxar, it is possible to eliminate senescent cells during the hepatic fibrosis process and maintain liver homeostasis [116]. The gene discussed is THBD; the disease is Hepatic fibrosis.